APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anxiety and Panic Disorders Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anxiety and Panic Disorders Drugs Industry Growth and Trends Forecast to 2032

Report ID 173966810120 December 202592 pages

Choose your research edition.

Industry ResearchAnxiety and Panic Disorders Drugs Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Anxiety and Panic Disorders Drugs Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Anxiety and Panic Disorders Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anxiety and Panic Disorders Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Anxiety and Panic Disorders Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Anxiety and Panic Disorders Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anxiety and Panic Disorders Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anxiety and Panic Disorders Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anxiety and Panic Disorders Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anxiety and Panic Disorders Drugs include Roche, Eli Lilly, Pfizer, GlaxoSmithKline, Baxter, AstraZeneca, Bristol-Myers Squibb and Azevan Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anxiety and Panic Disorders Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anxiety and Panic Disorders Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anxiety and Panic Disorders Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anxiety and Panic Disorders Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anxiety and Panic Disorders Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anxiety and Panic Disorders Drugs Market by Company

Roche

Eli Lilly

Pfizer

GlaxoSmithKline

Baxter

AstraZeneca

Bristol-Myers Squibb

Azevan Pharmaceuticals

Anxiety and Panic Disorders Drugs Segment by Type

Antidepressant Drugs

Anxiolytic Drugs

Anxiety and Panic Disorders Drugs Segment by Application

Hospitals

Clinics

Anxiety and Panic Disorders Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anxiety and Panic Disorders Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anxiety and Panic Disorders Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anxiety and Panic Disorders Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anxiety and Panic Disorders Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anxiety and Panic Disorders Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Antidepressant Drugs Table 2. Major Company of Anxiolytic Drugs Table 3. Global Anxiety and Panic Disorders Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Anxiety and Panic Disorders Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global Anxiety and Panic Disorders Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Anxiety and Panic Disorders Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Anxiety and Panic Disorders Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Anxiety and Panic Disorders Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Anxiety and Panic Disorders Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global Anxiety and Panic Disorders Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Anxiety and Panic Disorders Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Anxiety and Panic Disorders Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Anxiety and Panic Disorders Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Anxiety and Panic Disorders Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America Anxiety and Panic Disorders Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Anxiety and Panic Disorders Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe Anxiety and Panic Disorders Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Anxiety and Panic Disorders Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Anxiety and Panic Disorders Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Anxiety and Panic Disorders Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America Anxiety and Panic Disorders Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Anxiety and Panic Disorders Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Anxiety and Panic Disorders Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Anxiety and Panic Disorders Drugs Industry Trends Table 25. Anxiety and Panic Disorders Drugs Industry Drivers Table 26. Anxiety and Panic Disorders Drugs Industry Opportunities and Challenges Table 27. Anxiety and Panic Disorders Drugs Industry Restraints Table 28. Global Anxiety and Panic Disorders Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Anxiety and Panic Disorders Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Anxiety and Panic Disorders Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global Anxiety and Panic Disorders Drugs Sales Share by Company (2021-2026) Table 32. Global Anxiety and Panic Disorders Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Anxiety and Panic Disorders Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Anxiety and Panic Disorders Drugs Major Company Production Sites and Headquarters Table 35. Global Anxiety and Panic Disorders Drugs Company, Product Type & Application Table 36. Global Anxiety and Panic Disorders Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Anxiety and Panic Disorders Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Anxiety and Panic Disorders Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Anxiety and Panic Disorders Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global Anxiety and Panic Disorders Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Anxiety and Panic Disorders Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Anxiety and Panic Disorders Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Anxiety and Panic Disorders Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Anxiety and Panic Disorders Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Anxiety and Panic Disorders Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Anxiety and Panic Disorders Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Anxiety and Panic Disorders Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Anxiety and Panic Disorders Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Anxiety and Panic Disorders Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Anxiety and Panic Disorders Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Anxiety and Panic Disorders Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Anxiety and Panic Disorders Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Anxiety and Panic Disorders Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Anxiety and Panic Disorders Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Anxiety and Panic Disorders Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global Anxiety and Panic Disorders Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Anxiety and Panic Disorders Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Anxiety and Panic Disorders Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Anxiety and Panic Disorders Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Anxiety and Panic Disorders Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America Anxiety and Panic Disorders Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Anxiety and Panic Disorders Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe Anxiety and Panic Disorders Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Anxiety and Panic Disorders Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Anxiety and Panic Disorders Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Anxiety and Panic Disorders Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America Anxiety and Panic Disorders Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Anxiety and Panic Disorders Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Anxiety and Panic Disorders Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Roche Company Information Table 72. Roche Business Overview Table 73. Roche Anxiety and Panic Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Roche Anxiety and Panic Disorders Drugs Product Portfolio Table 75. Roche Recent Development Table 76. Eli Lilly Company Information Table 77. Eli Lilly Business Overview Table 78. Eli Lilly Anxiety and Panic Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Eli Lilly Anxiety and Panic Disorders Drugs Product Portfolio Table 80. Eli Lilly Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Anxiety and Panic Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Pfizer Anxiety and Panic Disorders Drugs Product Portfolio Table 85. Pfizer Recent Development Table 86. GlaxoSmithKline Company Information Table 87. GlaxoSmithKline Business Overview Table 88. GlaxoSmithKline Anxiety and Panic Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. GlaxoSmithKline Anxiety and Panic Disorders Drugs Product Portfolio Table 90. GlaxoSmithKline Recent Development Table 91. Baxter Company Information Table 92. Baxter Business Overview Table 93. Baxter Anxiety and Panic Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Baxter Anxiety and Panic Disorders Drugs Product Portfolio Table 95. Baxter Recent Development Table 96. AstraZeneca Company Information Table 97. AstraZeneca Business Overview Table 98. AstraZeneca Anxiety and Panic Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. AstraZeneca Anxiety and Panic Disorders Drugs Product Portfolio Table 100. AstraZeneca Recent Development Table 101. Bristol-Myers Squibb Company Information Table 102. Bristol-Myers Squibb Business Overview Table 103. Bristol-Myers Squibb Anxiety and Panic Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Bristol-Myers Squibb Anxiety and Panic Disorders Drugs Product Portfolio Table 105. Bristol-Myers Squibb Recent Development Table 106. Azevan Pharmaceuticals Company Information Table 107. Azevan Pharmaceuticals Business Overview Table 108. Azevan Pharmaceuticals Anxiety and Panic Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Azevan Pharmaceuticals Anxiety and Panic Disorders Drugs Product Portfolio Table 110. Azevan Pharmaceuticals Recent Development Table 111. North America Anxiety and Panic Disorders Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. North America Anxiety and Panic Disorders Drugs Sales by Country (2021-2026) & (K Units) Table 113. North America Anxiety and Panic Disorders Drugs Sales Market Share by Country (2021-2026) Table 114. North America Anxiety and Panic Disorders Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 115. North America Anxiety and Panic Disorders Drugs Sales Market Share Forecast by Country (2027-2032) Table 116. North America Anxiety and Panic Disorders Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Anxiety and Panic Disorders Drugs Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Anxiety and Panic Disorders Drugs Market Share by Country (2021-2026) Table 119. North America Anxiety and Panic Disorders Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Anxiety and Panic Disorders Drugs Market Share Forecast by Country (2027-2032) Table 121. Europe Anxiety and Panic Disorders Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Europe Anxiety and Panic Disorders Drugs Sales by Country (2021-2026) & (K Units) Table 123. Europe Anxiety and Panic Disorders Drugs Sales Market Share by Country (2021-2026) Table 124. Europe Anxiety and Panic Disorders Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 125. Europe Anxiety and Panic Disorders Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Anxiety and Panic Disorders Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Anxiety and Panic Disorders Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Anxiety and Panic Disorders Drugs Market Share by Country (2021-2026) Table 129. Europe Anxiety and Panic Disorders Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Anxiety and Panic Disorders Drugs Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Anxiety and Panic Disorders Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Anxiety and Panic Disorders Drugs Sales by Country (2021-2026) & (K Units) Table 133. Asia-Pacific Anxiety and Panic Disorders Drugs Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Anxiety and Panic Disorders Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 135. Asia-Pacific Anxiety and Panic Disorders Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Anxiety and Panic Disorders Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Anxiety and Panic Disorders Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Anxiety and Panic Disorders Drugs Market Share by Country (2021-2026) Table 139. Asia-Pacific Anxiety and Panic Disorders Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Anxiety and Panic Disorders Drugs Market Share Forecast by Country (2027-2032) Table 141. Latin America Anxiety and Panic Disorders Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Latin America Anxiety and Panic Disorders Drugs Sales by Country (2021-2026) & (K Units) Table 143. Latin America Anxiety and Panic Disorders Drugs Sales Market Share by Country (2021-2026) Table 144. Latin America Anxiety and Panic Disorders Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 145. Latin America Anxiety and Panic Disorders Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Anxiety and Panic Disorders Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Anxiety and Panic Disorders Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Anxiety and Panic Disorders Drugs Market Share by Country (2021-2026) Table 149. Latin America Anxiety and Panic Disorders Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Anxiety and Panic Disorders Drugs Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Anxiety and Panic Disorders Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Anxiety and Panic Disorders Drugs Sales by Country (2021-2026) & (K Units) Table 153. Middle East and Africa Anxiety and Panic Disorders Drugs Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Anxiety and Panic Disorders Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Anxiety and Panic Disorders Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Anxiety and Panic Disorders Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Anxiety and Panic Disorders Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Anxiety and Panic Disorders Drugs Market Share by Country (2021-2026) Table 159. Middle East and Africa Anxiety and Panic Disorders Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Anxiety and Panic Disorders Drugs Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Anxiety and Panic Disorders Drugs Distributors List Table 164. Anxiety and Panic Disorders Drugs Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Anxiety and Panic Disorders Drugs Image Figure 2. Global Anxiety and Panic Disorders Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anxiety and Panic Disorders Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Anxiety and Panic Disorders Drugs Sales (2021-2032) & (K Units) Figure 5. Antidepressant Drugs Image Figure 6. Global Antidepressant Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 7. Anxiolytic Drugs Image Figure 8. Global Anxiolytic Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Anxiety and Panic Disorders Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Anxiety and Panic Disorders Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Anxiety and Panic Disorders Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Anxiety and Panic Disorders Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Anxiety and Panic Disorders Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Anxiety and Panic Disorders Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Anxiety and Panic Disorders Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Anxiety and Panic Disorders Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Anxiety and Panic Disorders Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Anxiety and Panic Disorders Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Anxiety and Panic Disorders Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Anxiety and Panic Disorders Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Anxiety and Panic Disorders Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospitals Image Figure 24. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinics Image Figure 26. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Anxiety and Panic Disorders Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Anxiety and Panic Disorders Drugs Market Share by Application 2025 VS 2032 Figure 29. North America Anxiety and Panic Disorders Drugs Sales Market Share in Volume by Application in 2025 Figure 30. North America Anxiety and Panic Disorders Drugs Sales Market Share in Value by Application in 2025 Figure 31. Europe Anxiety and Panic Disorders Drugs Sales Market Share in Volume by Application in 2025 Figure 32. Europe Anxiety and Panic Disorders Drugs Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Anxiety and Panic Disorders Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Anxiety and Panic Disorders Drugs Sales Market Share in Value by Application in 2025 Figure 35. Latin America Anxiety and Panic Disorders Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Anxiety and Panic Disorders Drugs Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Anxiety and Panic Disorders Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Anxiety and Panic Disorders Drugs Sales Market Share in Value by Application in 2025 Figure 39. North America Anxiety and Panic Disorders Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Anxiety and Panic Disorders Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Anxiety and Panic Disorders Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Anxiety and Panic Disorders Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Anxiety and Panic Disorders Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Anxiety and Panic Disorders Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Anxiety and Panic Disorders Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Anxiety and Panic Disorders Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Anxiety and Panic Disorders Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Anxiety and Panic Disorders Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Anxiety and Panic Disorders Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Anxiety and Panic Disorders Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Anxiety and Panic Disorders Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Anxiety and Panic Disorders Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Anxiety and Panic Disorders Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Anxiety and Panic Disorders Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Anxiety and Panic Disorders Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Anxiety and Panic Disorders Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Anxiety and Panic Disorders Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Anxiety and Panic Disorders Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Anxiety and Panic Disorders Drugs Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Anxiety and Panic Disorders Drugs Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Antidepressant Drugs
  • Anxiolytic Drugs
Applications
  • Hospitals
  • Clinics
Companies covered
  • Roche
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • Baxter
  • AstraZeneca
  • Bristol-Myers Squibb
  • Azevan Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anxiety and Panic Disorders Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anxiety and Panic Disorders Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anxiety and Panic Disorders Drugs Market by Type
  6. 1.3.1 Antidepressant Drugs
  7. 1.3.2 Anxiolytic Drugs
  8. 1.4 Global Anxiety and Panic Disorders Drugs Market Size by Type
  9. 1.4.1 Global Anxiety and Panic Disorders Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Anxiety and Panic Disorders Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Anxiety and Panic Disorders Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Anxiety and Panic Disorders Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Anxiety and Panic Disorders Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Anxiety and Panic Disorders Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Anxiety and Panic Disorders Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Anxiety and Panic Disorders Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anxiety and Panic Disorders Drugs Industry Trends
  2. 2.2 Anxiety and Panic Disorders Drugs Industry Drivers
  3. 2.3 Anxiety and Panic Disorders Drugs Industry Opportunities and Challenges
  4. 2.4 Anxiety and Panic Disorders Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anxiety and Panic Disorders Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Anxiety and Panic Disorders Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Anxiety and Panic Disorders Drugs Price (2021-2026)
  4. 3.4 Global Anxiety and Panic Disorders Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anxiety and Panic Disorders Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Anxiety and Panic Disorders Drugs Company, Product Type & Application
  7. 3.7 Global Anxiety and Panic Disorders Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anxiety and Panic Disorders Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anxiety and Panic Disorders Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anxiety and Panic Disorders Drugs Tier 1, Tier 2, and Tier 3
4 Anxiety and Panic Disorders Drugs Regional Status and Outlook
  1. 4.1 Global Anxiety and Panic Disorders Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anxiety and Panic Disorders Drugs Historic Market Size by Region
  3. 4.2.1 Global Anxiety and Panic Disorders Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anxiety and Panic Disorders Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anxiety and Panic Disorders Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anxiety and Panic Disorders Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Anxiety and Panic Disorders Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anxiety and Panic Disorders Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anxiety and Panic Disorders Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anxiety and Panic Disorders Drugs by Application
  1. 5.1 Anxiety and Panic Disorders Drugs Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global Anxiety and Panic Disorders Drugs Market Size by Application
  5. 5.2.1 Global Anxiety and Panic Disorders Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Anxiety and Panic Disorders Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Anxiety and Panic Disorders Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Anxiety and Panic Disorders Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Anxiety and Panic Disorders Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Anxiety and Panic Disorders Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Anxiety and Panic Disorders Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Anxiety and Panic Disorders Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Roche Anxiety and Panic Disorders Drugs Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Eli Lilly
  8. 6.2.1 Eli Lilly Company Information
  9. 6.2.2 Eli Lilly Business Overview
  10. 6.2.3 Eli Lilly Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly Anxiety and Panic Disorders Drugs Product Portfolio
  12. 6.2.5 Eli Lilly Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Anxiety and Panic Disorders Drugs Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 GlaxoSmithKline
  20. 6.4.1 GlaxoSmithKline Company Information
  21. 6.4.2 GlaxoSmithKline Business Overview
  22. 6.4.3 GlaxoSmithKline Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline Anxiety and Panic Disorders Drugs Product Portfolio
  24. 6.4.5 GlaxoSmithKline Recent Developments
  25. 6.5 Baxter
  26. 6.5.1 Baxter Company Information
  27. 6.5.2 Baxter Business Overview
  28. 6.5.3 Baxter Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Baxter Anxiety and Panic Disorders Drugs Product Portfolio
  30. 6.5.5 Baxter Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca Anxiety and Panic Disorders Drugs Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 Bristol-Myers Squibb
  38. 6.7.1 Bristol-Myers Squibb Company Information
  39. 6.7.2 Bristol-Myers Squibb Business Overview
  40. 6.7.3 Bristol-Myers Squibb Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bristol-Myers Squibb Anxiety and Panic Disorders Drugs Product Portfolio
  42. 6.7.5 Bristol-Myers Squibb Recent Developments
  43. 6.8 Azevan Pharmaceuticals
  44. 6.8.1 Azevan Pharmaceuticals Company Information
  45. 6.8.2 Azevan Pharmaceuticals Business Overview
  46. 6.8.3 Azevan Pharmaceuticals Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Azevan Pharmaceuticals Anxiety and Panic Disorders Drugs Product Portfolio
  48. 6.8.5 Azevan Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Anxiety and Panic Disorders Drugs Sales by Country
  2. 7.1.1 North America Anxiety and Panic Disorders Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anxiety and Panic Disorders Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Anxiety and Panic Disorders Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anxiety and Panic Disorders Drugs Market Size by Country
  6. 7.2.1 North America Anxiety and Panic Disorders Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anxiety and Panic Disorders Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Anxiety and Panic Disorders Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anxiety and Panic Disorders Drugs Sales by Country
  2. 8.1.1 Europe Anxiety and Panic Disorders Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anxiety and Panic Disorders Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Anxiety and Panic Disorders Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anxiety and Panic Disorders Drugs Market Size by Country
  6. 8.2.1 Europe Anxiety and Panic Disorders Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anxiety and Panic Disorders Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anxiety and Panic Disorders Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anxiety and Panic Disorders Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Anxiety and Panic Disorders Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anxiety and Panic Disorders Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anxiety and Panic Disorders Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anxiety and Panic Disorders Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Anxiety and Panic Disorders Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anxiety and Panic Disorders Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anxiety and Panic Disorders Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anxiety and Panic Disorders Drugs Sales by Country
  2. 10.1.1 South America Anxiety and Panic Disorders Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anxiety and Panic Disorders Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Anxiety and Panic Disorders Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anxiety and Panic Disorders Drugs Market Size by Country
  6. 10.2.1 South America Anxiety and Panic Disorders Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anxiety and Panic Disorders Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Anxiety and Panic Disorders Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anxiety and Panic Disorders Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Anxiety and Panic Disorders Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anxiety and Panic Disorders Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anxiety and Panic Disorders Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anxiety and Panic Disorders Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Anxiety and Panic Disorders Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anxiety and Panic Disorders Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anxiety and Panic Disorders Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anxiety and Panic Disorders Drugs Value Chain Analysis
  2. 12.1.1 Anxiety and Panic Disorders Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anxiety and Panic Disorders Drugs Production Mode & Process
  7. 12.2 Anxiety and Panic Disorders Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anxiety and Panic Disorders Drugs Distributors
  10. 12.2.3 Anxiety and Panic Disorders Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst